This case report documents the extended survival of a female patient with glioblastoma multiforme (GBM), who lived over four years following diagnosis—far surpassing the typical median survival of around 12 months. Standard care included surgical resection, radiation, and temozolomide chemotherapy, alongside adjunctive high-dose intravenous vitamin C (IVC) therapy administered two
